Exact Mass: 376.2515
Exact Mass Matches: 376.2515
Found 500 metabolites which its exact mass value is equals to given mass value 376.2515
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
10-Apo-beta-carotenal
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
[12]-Gingerdione
[12]-Gingerdione is found in herbs and spices. [12]-Gingerdione is from Zingiber officinale (ginger). From Zingiber officinale (ginger). [12]-Gingerdione is found in herbs and spices.
MG(0:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
MG(0:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
MG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0/0:0)
MG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. [HMDB] MG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
9'-Carboxy-gamma-chromanol
9-Carboxy-gamma-tocopherol is a dehydrogenation carboxylate product of 9-hydroxy-r-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. r-Tocopherol provides different antioxidant activities in food and in-vitro studies and showed higher activity in trapping lipophilic electrophiles and reactive nitrogen and oxygen species. From the metabolism end product, only that of r-tocopherol (2,7,8-trimethyl-2-(b-carboxyethyl)-6-hydroxychroman), but not that of a-tocopherol, was identified to provide natriuretic activity. Only the r-tocopherol plasma level served as biomarker for cancer and cardiovascular risk.
10'-Apo-beta-carotenal
10-Apo-beta-carotenal belongs to the class of organic compounds known as sesterterpenoids. These are terpenes composed of five consecutive isoprene units. 10-Apo-beta-carotenal is a constituent of oranges and other citrus fruits. 10-Apo-beta-carotenal is a substrate for beta,beta-carotene 9,10-oxygenase. Constituent of oranges and other citrus fruits. 10-Apo-beta-caroten-10-al is found in citrus. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
Ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate
methyl (Z)-5-[(1R,4aR,8aR)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(acetyloxymethyl)pent-2-enoate
Di-Ac-(3beta,5alpha,13alpha,16alpha)-Androstane-3,16-diol
Enantio-18-acetoxy-labdien-8(20).13-15-saeuremethylester
turraeanin C|[16(E),12S,15R]-rel-16-acetoxy-12,15-epoxy-15-methoxy-ent-labda-8(17),13(16)-diene
3,6-dimethyl-6-( 8-phenyloctyl)-1 ,2-dioxane-3 -propanoic acid
(13E)-labd-7,13-diene-15-yl malonic acid|13(E)-labda-7,13-diene-15-ol malonate|lambda-7,13E-dien-15-yl malonate
7alpha,16alpha,17-trihydroxy-ent-kauran-6-one 16,17-acetonide|broussonetone C
17-Ac-(3beta,5alpha,17alphaOH)-3,17-Dihydroxypregnan-20-one
(-)-methyl solidagonate|methyl 7alpha-acetoxykolavenoate|methyl solidagonate|Solidagonsaeure-methylester
3-Ac-(3beta,5alpha,14beta,17alpha)-3,14-Dihydroxypregnan-20-one
Propanoyl-(ent-13E)-15-Hydroxy-1(10),13-halimadien-18-oic acid
methyl 15-acetoxy-1(10),13E-ent-halimene-18-oate|methyl-15-acetoxy-1(10),13E-ent-halimadien-18-oate|methyl-15-acetoxy-1(10),13E-halimadien-18-oate
6-(8Z-pentadecenyl)-1,2,4-trihydroxybenzene-1-O-acetate|ardisiphenol B
(3alpha,14beta)-3,18-[(1-methylethane-1,1,diyl)dioxy]-ent-abieta-7,15(17)-diene-14,16-diol|14beta,16-dihydroxy-3alpha,18-[(1-methylethane-1,1-diyl)dioxy]-ent-abieta-7,15(17)-diene
Ac-(ent-3beta,4beta,6beta,12Z)-3,4-Epoxy-6-hydroxy-12,14-clerodadien-20-oic acid|heteroscyphic acid C
ent-16beta,17-Dihydroxykauran-19-oic acid 16alpha,17-acetonide
16-Ac-15,16-Dihydroxy-3-erythroxylene-2,7-dione|16-O-acetyl-2,7-dioxofagonene
4a,10beta-epoxy-7-hydroxy-8-isopropyl-9,9-dimethoxy-1,1-dimethyl-2,3,4,4a,5,10,11,11abeta-octahydro-1H-dibenzo[a,d]cycloheptan-6(9H)-one|abrotanone
16-Acetoxy-trans-labda-8(14).13(15)-dien-19-saeure-methylester|Isocupressinsaeure-methylester-acetat|methyl (E)-15-acetoxylabda-8(17),13-dien-19-oate|methyl 15-O-acetylisocupressate|methyl acetylisocupressate|Methyl-15-acetoxy-8(17),E-13-labdadien-19-oat ( =Methylacetylisocupressat)|Methyl-15-acetoxy-8(17)-(E)-13-labdadien-19-oat|Methylisocupressat
ent-3,13E-clerodadien-15-yl-methyl malonic acid diester
15-Hydroxy-9-ketoprosta-5,8(12),13-trien-carbonsaeure
Methyl-19-acetoxy-8,(E)13-labdadien-15-oat|Methyl-19-hydroxy-8-E-13-labdadien-15-oatacetat
11-Acetoxy-labd-8(20)13-dien-15-carbonsaeuremethylester
rel-(3R,4S,5R,7S,9R)-3-acetoxy-9-(3-methylbutanoyloxy)solavetivone
methyl ent-16,17-dihydroxykauran-19-oic acid 16,17-acetonide
methyl 3beta-acetoxyanticopalate|methyl ester 3beta-acetoxyanticopalic acid
10-Ac-(Z)-5-(10-Hydroxy-8-pentadecenyl)-1,3-benzenediol|5-(10-acetoxy-pentadec-8Z-enyl)-Resorcinol
Rosthornin A
ent-12beta-acetoxy-7beta-hydroxykaur-16-en-19-oic acid
(Z)-2,5-dihydroxy-3-(heptadec-8-enyl)-1,4-benzoquinone|2-(heptadec-8-enyl)-3,6-dihydroxy-1,4-benzoquinone
4,7:14,16-Diepoxy-1(14),11,15-cembratriene-2,3-diol-2-Ac
ent-11alpha-acetoxy-7beta,14alpha-dihydroxy-16-kauren-15-one|ent-11alpha-acetoxy-7beta,14alpha-dihydroxykaur-16-en-15-one|ent-11??-Acetoxy-7??,14??-dihydroxykaur-16-en-15-one
C23H36O4_2-Pentenoic acid, 3-[(acetyloxy)methyl]-5-[(1R,4aR,8aR)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-, methyl ester, (2Z)
C22H32O5_2-Pentenoic acid, 3-[(acetyloxy)methyl]-5-[(1S,4aR,8aR)-2-formyl-1,4,4a,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-1-naphthalenyl]-, (2E)
C22H32O5_(2E)-3-(Acetoxymethyl)-5-[(1R,4aR,8aS)-2,5,5,8a-tetramethyl-4-oxo-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl]-2-pentenoic acid
C22H32O5_10H-Azuleno[4,5,6-cd]isobenzofuran-10-one, 9-(acetyloxy)-2,3,4,5,5a,6,7,7a,8,9,10a,10b-dodecahydro-3-hydroxy-5a,7a-dimethyl-8-(1-methylethyl)-, (3S,5aR,7aR,8R)
(E)-5-[(1S,4aR,8aR)-2-formyl-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-(acetyloxymethyl)pent-2-enoic acid
Resolvin D1-[d5]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0152.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0152.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0152.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001333.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001333.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001333.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001333.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001333.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001333.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
Resolvin D2-[d5]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0197.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0197.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0197.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000129.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000129.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000129.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000129.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000129.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000129.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
Resolvin D4
A member of the class of resolvins that is (6E,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying three hydroxy substituents at positions 4, 5 and 17 (the 4S,5R,17S-stereoisomer).
Prehumulone
Macrophorin C
9alpha-(Angeloyloxy)-4S-hydroxy-10(14)-oplopen-3-one 4-acetate
9alpha-(3-Methyl-2E-butenoyloxy)-4S-hydroxy-10(14)-oplopen-3-one 4-acetate
10'-apo-beta-carotenal
FA 22:6;O3
Resolvin D2
A member of the class of resolvins that is (4Z,8E,10Z,12E,14E,19Z)-docosahexaenoic acid carrying three hydroxy substituents at positions 7, 16 and 17 (the 7S,16R,17S-stereoisomer).
bhas#22
An (omega-1)-hydroxy fatty acid ascaroside that is ascr#22 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
bhos#22
An omega-hydroxy fatty acid ascaroside that is oscr#22 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
beta-Apo-10-carotenal
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(phenylmethyl)- (9CI)
1-(2-(benzyloxy)ethyl)-4-(tert-butyldimethylsilyloxy)cyclohexanecarbaldehyde
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(3,5-dimethylphenyl)- (9CI)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(2-ethylphenyl)- (9CI)
3-Benzyl-1-dodecyl-2-methyl-1H-imidazolium chloride
Ethyl 1-Boc-3-(1-phenylethylaMino)piperidine-4-carboxylate
7-Octenoic acid, 5,6-dihydroxy-8-(2-((1E,3R)-3-hydroxy-1-octenyl)phenyl)-, (5S,6R,7E)-
(4S,5R,6E,8E,10Z,13Z,15E,17S,19Z)-4,5,17-trihydroxydocosa-6,8,10,13,15,19-hexaenoic acid
(4S,5R,6E,8E,10Z,13Z,15E,17R,19Z)-4,5,17-trihydroxydocosa-6,8,10,13,15,19-hexaenoic acid
Ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D000970 - Antineoplastic Agents
(2E,4E,6Z,8E)-3-Methyl-7-(p-tolyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
(3R)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxytridecanoic acid
2-(1-Oxo-4-methylpentyl)-3,5,6-trihydroxy-4,6-bis(3-methyl-2-butenyl)-2,4-cyclohexadien-1-one
Methyl 3-(acetyloxymethyl)-5-(5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)pent-2-enoate
2-Methyl-3-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-1,4-naphthoquinone
(4Z,7S,8E,10Z,13Z,15E,17S,19Z)-7-hydroperoxy-17-hydroxydocosa-4,8,10,13,15,19-hexaenoic acid
7,8,17-Trihydroxy-4,9,11,13,15,19-docosahexaenoic acid
[(E)-3,7,11,15-tetramethylhexadec-2-enyl] dihydrogen phosphate
[3-Carboxy-2-(3,5-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,10-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,9-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,6-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,8-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,7-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,4-dihydroxydodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,11-dihydroxydodecanoyloxy)propyl]-trimethylazanium
10(R),17(S),20-trihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid
Ardisiphenol B
An acetate ester obtained from the formal condensation of acetic acid with the hydroxy group at position 1 of 6-[(8Z)-pentadec-8-en-1-yl]benzene-1,2,4-triol. Isolated from the dried fruits of Ardisia colorata, it exhibits scavenging activity towards DPPH radicals and cytotoxicity against murine breast cancer cell line, FM3A.
2-[8-(6-amino-1H-benzimidazol-2-yl)octyl]-3H-benzimidazol-5-amine
(1R,5R,6R)-5-hydroxy-4-(hydroxymethyl)-1-[(2E,6E,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-one
aspirin-triggered resolvin D2
A member of the class of resolvins that is (4Z,8E,10Z,12E,14E,19Z)-docosahexaenoic acid carrying three hydroxy substituents at positions 7, 16 and 17 (the 7S,16R,17R-stereoisomer).
3-hydroxy-3-[(2R,15S,17S)-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl]propanoic acid
3-Acetyl-5alpha-androstane-3beta,17beta-diol 3-acetate
(2S)-2-methylbutanoic acid [(1S,7S,8S,8aR)-8-[2-[(2R,4S)-4-hydroxy-2-oxanyl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester
2,3-dihydroxypropyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] acetate
7-Acetoxy-6-hexyl-3,4-dihydro-2-methyl-2H-1-benzopyran-2-ethanol acetate
[8-[2-(4-Hydroxyoxan-2-yl)ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2-methylbutanoate
[(2S)-2,3-dihydroxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate
[1-Carboxy-3-[2,3-di(butanoyloxy)propoxy]propyl]-trimethylazanium
[3-(3-Acetyloxy-2-hexanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
[1-Carboxy-3-(2-pentanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-hydroxy-3-nonanoyloxypropoxy)propyl]-trimethylazanium
aspirin-triggered resolvin D1
A member of the class of resolvins that consists of docosa-4Z,9E,11E,13Z,15E,19Z-hexaenoic acid carrying three hydroxy substituents at positions 7, 8, and 17 (the 7S,8R,17S-stereoisomer).
4(S)-hydroperoxy-17(S)-hydroxydocosahexaenoic acid
A hydroperoxy fatty acid that is (5E,7Z,10Z,13Z,15E,19Z)-docosa-5,7,10,13,15,19-hexaenoic acid carrying a hydroperoxy group at the 4S-position and a hydroxy group at the 17S-position.
4(S)-hydroperoxy-17(R)-hydroxydocosahexaenoic acid
A hydroperoxy fatty acid that is (5E,7Z,10Z,13Z,15E,19Z)-docosa-5,7,10,13,15,19-hexaenoic acid carrying a hydroperoxy group at the 4S-position and a hydroxy group at the 17R-position.
aspirin-triggered resolvin D4
A member of the class of resolvins that is (6E,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying three hydroxy substituents at positions 4, 5 and 17 (the 4S,5R,17R-stereoisomer).
(4Z,7R,8E,10Z,12E,14E,17S,19Z)-7,16,17-trihydroxydocosa-4,8,10,12,14,19-hexaenoic acid
5,6-Dihydroxy-2,6-bis(3-methylbut-2-enyl)-4-(4-methylpentanoyl)cyclohex-4-ene-1,3-dione
(3R,12R)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxytridecanoic acid
2-acylglycerol 20:5
A 2-monoglyceride in which the acyl group contains 20 carbons and 5 double bonds.
monoacylglycerol 20:5
A monoglyceride in which the acyl group contains a total of 20 carbon atoms and 5 double bonds at unspecified positions.
22-hydroxyprotectin D1
A docosanoid that is protectin D1 in which one of the terminal methyl hydrogens has been replaced by a hydroxy group. An intermediate of specialised proresolving mediators
7(S)-hydroperoxy-17(R)-hydroxydocosahexaenoic acid
A hydroperoxy fatty acid that is (4Z,8E,10Z,13Z,15E,19Z)-docosa-4,8,10,13,15,19-hexaenoic acid carrying a hydroperoxy group at the 7S-position and a hydroxy group at the 17R-position. It is an intermediate involved in the resolvin D1 biosynthesis pathway.
aspirin-triggered resolvin D3
A member of the class of resolvins that is (5Z,7E,9E,13Z,15E,19Z)-docosahexaenoic acid carrying three hydroxy substituents at positions 4, 11 and 17 (the 4S,11R,17R-stereoisomer)
2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycerol
A monoacylglycerol 20:5 in which the acyl group specified at position 2 is (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl.
Epoxypholamin E, (rel)-
A natural product found in Paraconiothyrium species.
yanuthone H
A class I yanuthone that is 22-deacetoxyyanuthone A in which one of the hydrogens of the trans-terminal methyl groups of the sesquiterpenoid side-chain has been replaced by a hydroxy group.
(1as,1bs,3r,3ar,5s,7br,9r,9ar)-3-hydroxy-1a-(hydroxymethyl)-5,7b-dimethyl-5-[(2s)-oxiran-2-yl]-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate
4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl acetate
2-hydroxy-5-methoxy-6-methyl-3-(pentadec-10-en-1-yl)cyclohexa-2,5-diene-1,4-dione
methyl (2e)-5-[(1s,4ar,8ar)-5,5,8a-trimethyl-2-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-3-[(acetyloxy)methyl]pent-2-enoate
(1s,9s,11r)-5-hydroxy-6-isopropyl-7,7-dimethoxy-12,12-dimethyl-16-oxatetracyclo[7.6.1.0¹,¹¹.0³,⁸]hexadeca-3(8),5-dien-4-one
3-hydroxy-1a-(hydroxymethyl)-5,7b-dimethyl-5-(oxiran-2-yl)-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate
[(2r,3e,5s)-2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-methoxyoxolan-3-ylidene]methyl acetate
(5r)-5-{[(1s,4ar,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-hydroxy-2-(hydroxymethyl)cyclohex-2-ene-1,4-dione
3-[(8z)-heptadec-8-en-1-yl]-2,5-dihydroxycyclohexa-2,5-diene-1,4-dione
5,12-dioxo-3-pentyl-3h,6h,7h,8h,11h,11ah,13h,14h,14ah-cyclopenta[e]oxacyclotridecan-14-yl acetate
(1r,4r,5r,9s,10s,13r)-13-hydroxy-5-(hydroxymethyl)-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
methyl (6e,7s,7ar)-7-hydroxy-3,7-dimethyl-6-[(3s)-3-methyl-2-oxononylidene]-1h,7ah-cyclopenta[c]pyran-5-carboxylate
(2r,4r,4as,4bs,5r,7s,10as)-4,5-dihydroxy-7-(3-hydroxyprop-1-en-2-yl)-1,1,4a-trimethyl-2,3,4,4b,5,6,7,10a-octahydrophenanthren-2-yl acetate
(1s,3s,4e,7e,11r,12s)-3-hydroxy-4,8,12-trimethyl-15-methylidene-14-oxo-13-oxabicyclo[10.3.2]heptadeca-4,7-dien-11-yl acetate
2-(acetyloxy)-4a,5-dimethyl-7-oxo-3-(prop-1-en-2-yl)-octahydronaphthalen-1-yl 2-methylbut-2-enoate
2-{[4-(3-hydroxybutyl)-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
15-(3,5-dihydroxyphenyl)pentadec-7-en-6-yl acetate
3-[1-(4,4,7a-trimethyl-hexahydro-1h-inden-1-yl)ethenyl]-5-oxo-tetrahydro-2h-furo[2,3-b]furan-2-yl acetate
(2r)-2-[(1r,3s)-1,3-dimethoxy-5-[(1s)-1,3,3-trimethylcyclohexyl]-1,3-dihydro-2-benzofuran-4-yl]propanoic acid
(3ar,5s,6r,15as)-6-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-5-yl acetate
2,16-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.0³,⁵.0⁸,¹⁰]heptadecan-12-yl acetate
(3as,4s,6r,7s)-7-[2-(acetyloxy)propan-2-yl]-1,4-dimethyl-2-oxo-3a,4,5,6,7,8-hexahydro-3h-azulen-6-yl (2z)-2-methylbut-2-enoate
methyl (2e)-5-[(1s,4ar,6s,8ar)-6-(acetyloxy)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-enoate
(1z,2s,3ar,5s,6s,7s,7ar)-2-(acetyloxy)-1-ethylidene-6-hydroxy-7-isopropyl-4-methylidene-hexahydro-2h-inden-5-yl (2z)-2-methylbut-2-enoate
(2z)-5-[(1r,4ar,8as)-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-3-[(acetyloxy)methyl]pent-2-enoic acid
(1s,2s,5s,8s,9r,11r,13s,16s,18r)-16-ethoxy-13,18-dihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one
5-hydroxy-1-[1-hydroxy-3-methyl-5-(1,2,6-trimethylcyclohex-2-en-1-yl)pent-2-en-1-yl]-4-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
(1r,3ar,4r,5s,7as)-1,3,4,5,7-pentamethyl-5-[(1e,3e)-2-methyl-4-phenylbuta-1,3-dien-1-yl]-3a,7a-dihydro-1h-indene-4-carboxylic acid
[(2s,3e,5r)-2-{[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-methoxyoxolan-3-ylidene]methyl acetate
3-{[9-(2,2-dimethyl-6-methylidenecyclohexyl)-3,7-dimethylnona-2,6-dien-1-yl]oxy}-3-oxopropanoic acid
(1s,2s,3r,4r,7s,8r,11s,14z,17s)-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-4-yl acetate
(6r)-6-[(1e,3r,4e)-5-[(2r,6r)-6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl]-3-methylhexa-1,4-dien-1-yl]-3-(hydroxymethyl)-4-methoxy-5,6-dihydropyran-2-one
[7-(acetyloxy)-4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl]acetic acid
3-hydroxy-5,5,9,15-tetramethyl-16-oxo-11-oxapentacyclo[12.2.1.0¹,¹⁰.0⁴,⁹.0¹⁰,¹²]heptadecan-8-yl acetate
(1r,4s,5r,6s,9r,10s,11s,13s)-11-hydroxy-5-(hydroxymethyl)-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
(1r,2r,3s,4s,5s,7r,8s,11s,17r)-5,8,11-trimethyl-15-methylidene-12-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate
5,7-dimethoxy-14,14-dimethyl-6-oxatetracyclo[9.2.1.0⁴,¹².0⁸,¹²]tetradec-3-en-2-yl 2-methylbut-2-enoate
[(1s,4s,4ar,8as)-4-(acetyloxy)-5,5,8a-trimethyl-1-[(1e)-3-oxobut-1-en-1-yl]-1,4,4a,6,7,8-hexahydronaphthalen-2-yl]methyl acetate
(1r,4s,5r,9r,10s,11s,13r)-13-hydroxy-5-(hydroxymethyl)-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,3s,5s,8s,10s,12r,13r)-5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.0³,⁵.0⁸,¹⁰]heptadecan-12-yl acetate
(1r,2r,3s,8ar,10ar)-3-hydroxy-5-(hydroxymethyl)-1-isopropyl-8a,10a-dimethyl-6-oxo-1h,2h,3h,7h,8h,9h,10h-cyclohexa[f]azulen-2-yl acetate
1-acetyl-6-(acetyloxy)-7-isopropyl-4-methylidene-octahydroinden-2-yl 2-methylbut-2-enoate
(1r,2s,5r,7r,8s,9s,10s,11r)-7,9-dihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-10-yl acetate
(1r,2s,4e,8e,12r,13r)-12-hydroxy-4,8,12-trimethyl-16-methylidene-15-oxo-14-oxabicyclo[11.3.1]heptadeca-4,8-dien-2-yl acetate
(1r,5s,6r)-1-{[(1s,4ar,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-5-hydroxy-4-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
(1r,2s,5s,6r,9s,13r)-14-formyl-2-hydroxy-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-6-yl acetate
(1s,3s,4s,6s,9r,10s,11s,13s)-6,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
3-{[(2e,6e)-9-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-3,7-dimethylnona-2,6-dien-1-yl]oxy}-3-oxopropanoic acid
10a-hydroxy-4,4,7,11b-tetramethyl-9-oxo-1h,2h,3h,4ah,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
2a,4-dihydroxy-6,8b-dimethyl-6-(oxiran-2-yl)-1h,2h,2bh,3h,4h,4ah,5h,7h,9h,10h,10ah-cyclobuta[a]phenanthren-10-yl acetate
(1'r,2r,2's,4'r,9's,10's,13's)-2'-hydroxy-5,5,5',5',9'-pentamethylspiro[1,4-dioxolane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3'-one
(1s,2r,4ar,8ar)-1-(acetyloxy)-1,4a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydronaphthalen-2-yl 2-methylbut-2-enoate
12-isopropyl-5,9-dimethyl-3,15-dioxo-14-oxabicyclo[11.2.1]hexadeca-1(16),8-dien-11-yl acetate
2,4-dihydroxy-6-(pentadec-8-en-1-yl)phenyl acetate
7-{2-[3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl}hept-5-enoic acid
methyl (2e)-5-[(1s,2r,4r,4ar,8ar)-4-(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate
(1s,4ar,5r,6as,7r,11as,11bs)-1,4a-dihydroxy-4,4,7,11b-tetramethyl-1h,2h,3h,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
3-oxo-3-{[(1s,2s,7s,10s,12r,13s)-2,6,6,13-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0²,⁷]hexadecan-12-yl]oxy}propanoic acid
5-hydroxy-4-(hydroxymethyl)-1-{[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-7-oxabicyclo[4.1.0]hept-3-en-2-one
(2''r,3r,4''as,5's,8''as)-2'',5'',5'',8''a-tetramethyl-3''-oxo-4''a,6'',7'',8''-tetrahydro-2h,4''h-dispiro[furan-3,2'-oxolane-5',1''-naphthalen]-2''-yl acetate
[(1r,2s,4r,5s,6r,9s,10s,13r)-14-formyl-2,6-dihydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl acetate
18-acetoxy-7α,14β-dihydroxykaur-16-en-15-one
{"Ingredient_id": "HBIN002085","Ingredient_name": "18-acetoxy-7\u03b1,14\u03b2-dihydroxykaur-16-en-15-one","Alias": "NA","Ingredient_formula": "C22H32O5","Ingredient_Smile": "CC(=O)OCC1(CCCC2(C1CC(C34C2CCC(C3O)C(=C)C4=O)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "173","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-acetoxy-7α,14β-dihydroxykaur-16-en-15-one
{"Ingredient_id": "HBIN002380","Ingredient_name": "1\u03b2-acetoxy-7\u03b1,14\u03b2-dihydroxykaur-16-en-15-one","Alias": "NA","Ingredient_formula": "C22H32O5","Ingredient_Smile": "CC(=O)OC1CCC(C2C1(C3CCC4C(C3(C(C2)O)C(=O)C4=C)O)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "171","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-hydroxy-n-isopentenyldendroxine
{"Ingredient_id": "HBIN012463","Ingredient_name": "6-hydroxy-n-isopentenyldendroxine","Alias": "6-hydroxy- n -isopentenyldendroxine","Ingredient_formula": "C22H34NO4(+)","Ingredient_Smile": "NA","Ingredient_weight": "376.515","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7543;7558","PubChem_id": "NA","DrugBank_id": "NA"}
alangionoside J
{"Ingredient_id": "HBIN015034","Ingredient_name": "alangionoside \uff2a","Alias": "NA","Ingredient_formula": "C19H36O7","Ingredient_Smile": "CC1CC(CC(C1CCC(C)O)(C)C)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35356","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}